APA

Yang Y., Zhu Y., Cao J., Zhang Y., Xu L., Yuan Z., Wu J., Wang W., Wu T., Lu B., Zhu S., Qian L., Zhang F., Hou X. & Li Y. (20151215). Risk-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma: analysis from a multicenter study. : Blood.

Chicago

Yang Yong, Zhu Yuan, Cao Jian-Zhong, Zhang Yu-Jing, Xu Li-Ming, Yuan Zhi-Yong, Wu Jun-Xin, Wang Wei, Wu Tao, Lu Bing, Zhu Su-Yu, Qian Li-Ting, Zhang Fu-Quan, Hou Xiao-Rong and Li Ye-Xiong. 20151215. Risk-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma: analysis from a multicenter study. : Blood.

Harvard

Yang Y., Zhu Y., Cao J., Zhang Y., Xu L., Yuan Z., Wu J., Wang W., Wu T., Lu B., Zhu S., Qian L., Zhang F., Hou X. and Li Y. (20151215). Risk-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma: analysis from a multicenter study. : Blood.

MLA

Yang Yong, Zhu Yuan, Cao Jian-Zhong, Zhang Yu-Jing, Xu Li-Ming, Yuan Zhi-Yong, Wu Jun-Xin, Wang Wei, Wu Tao, Lu Bing, Zhu Su-Yu, Qian Li-Ting, Zhang Fu-Quan, Hou Xiao-Rong and Li Ye-Xiong. Risk-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma: analysis from a multicenter study. : Blood. 20151215.